Evidence map›Paper›PMID 33525473›Full record

ArticleInternational journal of molecular sciences2021

Gliadin, through the Activation of Innate Immunity, Triggers lncRNA NEAT1 Expression in Celiac Disease Duodenal Mucosa.

Elisa Gnodi, Clara Mancuso, Luca Elli, Elisa Ballarini, Raffaella Meneveri, Jean François Beaulieu, Donatella Barisani

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Gluten Is Not Gluten.Nutrients · 2024
    Article
  5. Article
  6. Celiac disease: From genetics to epigenetics.World journal of gastroenterology · 2022
    Review
  7. A Novel Regulatory Player in the Innate Immune System: Long Non-Coding RNAs.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Elisa GnodiSchool of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.ORCID 0000-0002-4390-6633
Clara MancusoSchool of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.
Luca ElliCentre for the Prevention and Diagnosis of Celiac Disease, Gastroenterology and Endoscopy Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.ORCID 0000-0002-0873-0759
Elisa BallariniSchool of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.
Raffaella MeneveriSchool of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.
Jean François BeaulieuLaboratory of Intestinal Physiopathology, Faculty of Medicine and Health Sciences, Université de Sherbrooke and Research Center of the Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.ORCID 0000-0002-8977-3629
Donatella BarisaniSchool of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.ORCID 0000-0003-4592-6221
University of Milano-Bicocca · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITUniversité de Sherbrooke · CA

Funding

Università degli Studi di Milano-Bicocca 2018-ATE-0297Università degli Studi di Milano-Bicocca 2019-ATE-0403
6 · The paper itself

Abstract

Celiac disease (CD) is an autoimmune enteropathy arising in genetically predisposed subjects exposed to gluten, which activates both innate and adaptive immunity. Although the pathogenesis is common to all patients, the clinical spectrum is quite variable, and differences could be explained by gene expression variations. Among the factors able to affect gene expression, there are lncRNAs. We evaluated the expression profile of 87 lncRNAs in CD vs. healthy control (HC) intestinal biopsies by RT-qPCR array. Nuclear enriched abundant transcript 1 (NEAT1) and taurine upregulated gene 1 (TUG1) were detected as downregulated in CD patients at diagnosis, but their expression increased in biopsies of patients on a gluten-free diet (GFD) exposed to gluten. The increase in NEAT1 expression after gluten exposure was mediated by IL-15 and STAT3 activation and binding to the NEAT1 promoter, as demonstrated by gel shift assay. NEAT1 is localized in the nucleus and can regulate gene expression by sequestering transcription factors, and it has been implicated in immune regulation and control of cell proliferation. The demonstration of its regulation by gluten thus also supports the role of lncRNAs in CD and prompts further research on these RNAs as gene expression regulators.

Indexed as

Down-RegulationAdultCase-Control StudiesCeliac DiseaseCell ProliferationCells, CulturedChildDuodenumFemaleGene Expression RegulationGliadinHumansImmunity, InnateInterleukin-15Intestinal MucosaMaleGliadinIL15 protein, humanInterleukin-15NEAT1 long non-coding RNA, humanRNA, Long NoncodingSTAT3 protein, humanSTAT3 Transcription FactorTUG1 long noncoding RNA, humanceliac diseaseinnate immunitylong non-coding RNAsNEAT1TUG1

Identifiers

PMID33525473
PMCPMC7865487
OpenAlexW3123153224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.